###begin article-title 0
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 60 65 <span type="species:ncbi:9606">Women</span>
Risk Alleles of USF1 Gene Predict Cardiovascular Disease of Women in Two Prospective Studies
###end article-title 0
###begin p 1
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1152 1156 1152 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1257 1261 1257 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1375 1376 1375 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1458 1459 1458 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1506 1510 1506 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1681 1685 1681 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
Upstream transcription factor 1 (USF1) is a ubiquitously expressed transcription factor controlling several critical genes in lipid and glucose metabolism. Of some 40 genes regulated by USF1, several are involved in the molecular pathogenesis of cardiovascular disease (CVD). Although the USF1 gene has been shown to have a critical role in the etiology of familial combined hyperlipidemia, which predisposes to early CVD, the gene's potential role as a risk factor for CVD events at the population level has not been established. Here we report the results from a prospective genetic-epidemiological study of the association between the USF1 variants, CVD, and mortality in two large Finnish cohorts. Haplotype-tagging single nucleotide polymorphisms exposing all common allelic variants of USF1 were genotyped in a prospective case-cohort design with two distinct cohorts followed up during 1992-2001 and 1997-2003. The total number of follow-up years was 112,435 in 14,140 individuals, of which 2,225 were selected for genotyping based on the case-cohort study strategy. After adjustment for conventional risk factors, we observed an association of USF1 with CVD and mortality among females. In combined analysis of the two cohorts, female carriers of a USF1 risk haplotype had a 2-fold risk of a CVD event (hazard ratio [HR] 2.02; 95% confidence interval [CI] 1.16-3.53; p = 0.01) and an increased risk of all-cause mortality (HR 2.52; 95% CI 1.46-4.35; p = 0.0009). A putative protective haplotype of USF1 was also identified. Our study shows how a gene identified in exceptional families proves to be important also at the population level, implying that allelic variants of USF1 significantly influence the prospective risk of CVD and even all-cause mortality in females.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin p 3
###xml 430 468 430 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upstream transcription factor 1 (USF1)</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
Better characterization of molecular events resulting in cardiovascular disease (CVD) requires elucidation of genetic background of CVD. After a CVD candidate gene is identified in family-based studies or case-control studies, population-based prospective studies are needed to demonstrate any potential impact of allelic variants on the CVD risk at the population level. This study addresses the role of different alleles of the upstream transcription factor 1 (USF1) gene, encoding a transcription factor and originally associated with familial combined hyperlipidemia in rare families with multiple affected individuals. The product of USF1 regulates numerous genes of lipid and glucose metabolism, and the authors show in large population cohorts that specific alleles of USF1 are associated with the risk of CVD and all-cause mortality among females. The study implies an interesting female-specific risk effect, and should stimulate additional studies of the sex-specific CVD risk genes in different populations.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 4 42 4 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upstream transcription factor 1 (USF1)</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b001">1</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b003">3</xref>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b004">4</xref>
The upstream transcription factor 1 (USF1) gene encoding USF1, a ubiquitously expressed transcription factor controlling some 40 genes [1], based on its function is an attractive candidate gene for cardiovascular disease (CVD). Initially this gene was identified as the first familial combined hyperlipidemia (FCHL) gene in rare Finnish pedigrees with multiple affected individuals having a greatly increased risk for CVD [2]. This finding was rapidly replicated in Mexican families [3], and since then USF1 has also been associated with the metabolic syndrome and type II diabetes in study samples ascertained for these traits [4].
###end p 5
###begin p 6
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 621 625 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 819 823 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1067 1072 <span type="species:ncbi:9606">women</span>
Thus, the combined evidence indicates a role for USF1 in the molecular background of hyperlipidemias, yet the direct contribution of the USF1 gene to CVD at the population level has not been addressed. To adequately evaluate the impact of a gene or a risk allele on the disease risk at the population level requires a prospective follow-up study, a golden standard in traditional epidemiology, in which risk factor(s) are measured at the beginning of the follow-up, and the diagnostic endpoints are registered as the study proceeds. We have in this study used two unique cohorts from Finland, the population in which the USF1 gene was identified as an FCHL gene, to address the general significance of the USF1 gene as a risk factor for CVD in population-based, prospective manner. We evaluated allelic variants of the USF1 gene by genotyping haplotype-tagging single-nucleotide polymorphisms (htSNPs) of the USF1 locus and assessing their association with CVD events in the two prospective cohorts. Specific alleles of the USF1 gene proved to modify the CVD risk in women and to contribute both to CVD and mortality at the population level.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g001">Figure 1</xref>
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b005">5</xref>
###xml 510 518 510 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g001">Figure 1</xref>
###xml 523 531 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t001">Tables 1</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t002">2</xref>
###xml 268 274 <span type="species:ncbi:9606">person</span>
###xml 325 331 <span type="species:ncbi:9606">person</span>
###xml 366 372 <span type="species:ncbi:9606">person</span>
Figure 1 shows characteristics of the two FINRISK [5] cohorts. The number of individuals recruited in the FINRISK-97 cohort was larger than in the FINRISK-92 at the baseline of the study. However, since the follow-up time was shorter for the FINRISK-97, the number of person-years was smaller for this younger cohort (54,577 person-years in FINRISK-97 versus 57,858 person-years in FINRISK-92). We selected incident cases and random subcohorts from the FINRISK cohorts for genotyping of six htSNPs as shown in Figure 1 and Tables 1 and 2.
###end p 8
###begin p 9
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 433 441 433 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g002">Figure 2</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b006">6</xref>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
The genotype frequencies of all six SNPs followed Hardy-Weinberg equilibrium at the 0.05 level among the subcohorts of the FINRISK study samples. The linkage disequilibrium (LD) structure of the USF1 gene and haplotype tagging properties of the genotyped SNPs were examined combining the two subcohorts. The selected six htSNPs captured the common haplotypes of USF1 well (all haplotypes with frequency > 4% in SeattleSNPs database (Figure 2) [6]). Due to the high LD across the USF1 gene locus (D' 0.995-1.000 between all SNP pairs), only five haplotypes were observed. Importantly, based on the distribution of the SNP alleles into various haplotypes, it was evident that the SNP alleles unequivocally specified haplotypes; thus, the selected SNPs truly represented htSNPs for this gene.
###end p 9
###begin p 10
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 88 95 88 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t003">Table 3</xref>
###xml 127 136 127 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 554 564 554 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279,</italic>
###xml 588 598 588 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658,</italic>
###xml 715 716 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 906 910 906 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 932 941 932 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 963 967 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1003 1012 1003 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 1054 1058 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1060 1068 1060 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g002">Figure 2</xref>
The minor allele frequencies of the USF1 SNPs varied from 11% to 41% in the subcohorts (Table 3). In both FINRISK cohorts, SNP rs2073658 showed a difference in the minor allele frequency between the female incident CVD cases and the subcohort free of CVD (p = 0.05 for FINRISK-92 and FINRISK-97 combined). This SNP represents the variant previously associated with FCHL in Finnish pedigrees, and in both cohorts the minor allele seemed to be more prevalent among incident female CVD cases when compared to subcohort females free of CVD. For another SNP, rs2774279, located 6.8 kb 5' from rs2073658, the minor allele frequency was higher among the subcohort females free of CVD than among incident female CVD cases (p = 0.03 for FINRISK-92 and FINRISK-97 combined), especially in the FINRISK-92 (p = 0.008) study sample with a longer follow-up. The minor alleles of these two SNPs both tag one haplotype of USF1. The minor allele of rs2073658 tags the most common USF1 haplotype, and the minor allele of rs2774279 tags the second most common haplotype of USF1 (Figure 2).
###end p 10
###begin p 11
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 262 269 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t004">Table 4</xref>
###xml 404 413 404 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b001">1</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b004">4</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b007">7</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b008">8</xref>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 989 999 989 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279,</italic>
###xml 1174 1183 1174 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 1213 1214 1213 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1367 1376 1367 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 1415 1416 1415 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1534 1543 1534 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 1638 1639 1638 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1713 1722 1713 1722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 1816 1817 1816 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Cox proportional hazards regression analysis measuring time-to-event was used to estimate the risk of an incident CVD event or mortality during the follow-up period in relation to the USF1 SNPs. Allele-specific hazard ratios for the six SNPs tested are shown in Table 4 for analyses testing the two FINRISK cohorts separately and for analyses pooling the cohorts. Analysis of the previously analyzed SNP rs2073658 [1-4,7,8] revealed an increased risk of incident CVD (HR 2.02; 95% confidence interval [CI] 1.16-3.53; p = 0.01) and all-cause mortality (HR 2.52; 95% CI 1.46-4.35; p = 0.0009) for carriers of T-allele among females when compared to noncarriers of the allele. The increased risk was evident especially among the FINRISK-97 females; however, the hazard ratio was increased also among the FINRISK-92 females, although it did not reach statistical significance. The second SNP showing a difference in the minor allele frequency between incident cases and subcohort free of CVD, rs2774279, was also associated with increased risk of incident CVD and mortality in time-to-event analysis. Risk of mortality was increased among the female carriers of the G-allele of rs2774279 (HR 4.43; 95% CI 1.58-12.40; p = 0.005). Again, the increased risk was observed especially among the FINRISK-97 females. Also, the risk of CVD was higher among female carriers of the rs2774279 G-allele (HR 4.01; 95% CI 1.30-12.39; p = 0.02), and the effect of the SNP was observed in both FINRISK cohorts. Among FINRISK-97 females, the effect of SNP rs2774279 was visible when comparing carriers of the G-allele with others (HR 15.38; 95% CI 2.49-94.87; p = 0.003). Interestingly, among the FINRISK-92 females, the effect of SNP rs2774279 was observed when comparing carriers of the A-allele with others (HR 0.33; 95% CI 0.13-0.85; p = 0.02).
###end p 11
###begin p 12
###xml 255 264 255 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2516839</italic>
###xml 293 294 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 601 610 601 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
No significant associations with the risk of an incident CVD event or mortality were observed among males in combined analysis of the two cohorts. Among FINRISK-92 males, a suggestive association was obtained for risk of mortality and the T-allele of SNP rs2516839 (HR 1.83; 95% CI 1.00-3.36; p = 0.05), and including FINRISK-92 females to the analysis further strengthened the results (HR 1.86; 95% CI 1.13-3.05; p = 0.01). Otherwise, the only association seen in the pooled analyses of males and females was a decreased risk of CVD (HR 0.53; 95% CI 0.30-0.95; p = 0.03) observed for carriers of the rs2073658 C-allele when compared to noncarriers of the allele among the FINRISK-92 cohort.
###end p 12
###begin p 13
###xml 53 54 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 548 549 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t004">Table 4</xref>
We used permutation analysis to determine a critical p-value for 5% level of significance corrected for multiple testing for our results; we permuted the genotype while retaining the phenotype data and repeated the same analyses that were performed with the actual dataset and repeated this procedure 1,000 times. In the time-to-event analyses where FINRISK-92 males and females were pooled together, permutation analysis suggested a critical p-value of 0.005 for a 5% level of significance for both CVD risk and mortality risk. All other critical p-values obtained from permutation analysis can be seen in Table 4.
###end p 13
###begin p 14
###xml 115 122 115 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t002">Table 2</xref>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 197 200 <span type="species:ncbi:9606">men</span>
In our age-stratified study samples, the average age of the onset of CVD was about the same for males and females (Table 2). Since females generally have their first CVD event at an older age than men, we tested whether the observed sex difference was primarily due to a possible difference in relative age at event for males and females in our study sample. The time-to-event analysis combined for the two cohorts was repeated for males who had their first CVD event early (before age 55; n = 70), but no associations with CVD or mortality were observed (unpublished data).
###end p 14
###begin p 15
###xml 66 75 66 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 89 98 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 211 220 211 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g002">Figure 2</xref>
###xml 361 370 361 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 966 967 966 967 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 1021 1022 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1143 1144 1143 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The time-to-event results of individual htSNPs suggested that the rs2073658 T-allele and rs2774279 G-allele increase the risk of CVD and mortality among females. From the USF1 haplotypes it was obvious that the rs2073658 T-allele was present only in haplotype CTCTAG (population frequency 34%) (Figure 2), thus specifying it as a risk-increasing haplotype. The rs2774279 G-allele was present in all other haplotypes but the CCCTAA haplotype (population frequency 29%), thus implying a protective role for this haplotype. We wanted to investigate more closely how the carriership of these haplotypes relates to the risk of CVD and mortality. Time-to-event analysis was performed to estimate the risk of CVD for females carrying the risk haplotype CTCTAG without the protective haplotype CCCTAA. The females carrying the risk haplotype CTCTAG, but without the protective haplotype CCCTAA, had the highest CVD risk when compared to any other group of haplotype carriers, this risk being 2.8-fold (HR 2.77; 95% CI 1.50-5.13; p = 0.001). This result remained significant after correcting for multiple testing: In permutation analysis, the critical p-value for 5% significance level was 0.003.
###end p 15
###begin p 16
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 412 420 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t005">Tables 5</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020069-st001">S1</xref>
Finally, we tested whether the sequence variants of USF1 have an effect on lipids, body mass index (BMI), or waist-to-hip circumference ratio, the traits characteristic of FCHL and other conditions with earlier-reported associations with USF1 and known contributors to the CVD risk. The obtained results support previous findings of the best association observed for lipid values in males, and are summarized in Tables 5 and S1.
###end p 16
###begin p 17
###xml 213 222 213 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 314 323 314 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2516839</italic>
###xml 325 326 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 369 378 369 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1556259</italic>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 453 462 453 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774276</italic>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
When males and females were analyzed together, significant associations among incident CVD cases were seen with higher levels of cholesterol and non-high-density lipoprotein (HDL) cholesterol with the C-allele of rs2073658 (p = 0.02 and p = 0.02 for cholesterol and non-HDL cholesterol, respectively), C-allele of rs2516839 (p < 0.0001 and p = 0.0001), and G-allele of rs1556259 (p = 0.01 and p = 0.03). Among the subcohort free of CVD, the G-allele of rs2774276 was associated with higher waist-to-hip ratios (p = 0.009). For all these pooled analyses the critical p-value for 5% significance level was 0.006.
###end p 17
###begin title 18
Discussion
###end title 18
###begin p 19
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
We previously established the association of the USF1 gene with FCHL in a set of rare Finnish families with multiple dyslipidemic individuals [2], known to be predisposed to a significantly increased risk for CVD. Here we show that allelic variants of the USF1 gene have an impact on CVD risk also at the population level, a finding rarely established for any complex disease gene so far.
###end p 19
###begin p 20
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b003">3</xref>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b008">8</xref>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 684 685 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b004">4</xref>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 867 868 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b009">9</xref>
###xml 928 929 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b007">7</xref>
###xml 996 1000 996 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1065 1069 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 862 865 <span type="species:ncbi:9606">men</span>
###xml 921 926 <span type="species:ncbi:9606">women</span>
The biological importance of the USF1 gene has been implied in several studies reporting an association between USF1 and disorders of lipid and glucose metabolism, mostly in study samples ascertained for these traits. Following the first association report for USF1 with FCHL in Finnish FCHL families [2], the association was replicated in Mexican FCHL families [3]. Further, in Utah pedigrees ascertained for early death due to coronary heart disease (CHD), early stroke, or early-onset of hypertension, USF1 was found to be associated with FCHL-related lipid traits, especially in males [8]. USF1 has also been implicated in the etiology of metabolic syndrome and type II diabetes [4], common conditions predisposing to premature CVD. Additional studies show variants of USF1 as being associated with features of glucose and lipid homeostasis in healthy young men [9] and increased adipocyte lipolysis in healthy obese women [7]. Although multiple studies have provided evidence of the role of USF1 in CVD-associated dyslipidemias, the direct contribution of the USF1 gene to CVD and mortality at the population level has not been assessed.
###end p 20
###begin p 21
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1,</italic>
Here we prospectively followed up two distinct cohorts representative of the general Finnish population of the study areas. Using Cox proportional hazards regression analysis measuring time-to-event, we found a female-specific association of two USF1 htSNPs, defining a "risk allele" of USF1, with both CVD and all-cause mortality. We also tentatively identified a "protective" allele for this gene.
###end p 21
###begin p 22
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 197 206 197 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 296 306 296 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658,</italic>
###xml 730 739 730 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 1107 1111 1107 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1409 1413 1409 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 1448 1449 1448 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 1450 1451 1450 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b008">8</xref>
###xml 1482 1483 1482 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b009">9</xref>
The USF1 risk allele identified here for the cohort females differs from the risk allele segregating in FCHL families. In 60 Finnish FCHL families the risk was associated with the common allele of rs2073658 [2], whereas in the present study the SNP haplotype CTCTAG, carrying the minor allele of rs2073658, was associated with a risk effect. However, our original FCHL study did not address the female risk allele in any detail, since the most significant association was observed in males with high triglycerides. We performed a simple analysis of the original FCHL data, choosing families (32 out of 60) in which at least 50% of those affected were female. Among these affected FCHL females the frequency of the minor allele of rs2073658 (haplotype CTCTAG seen in FINRISK females) was higher than among the unaffected females of those families (45% versus 38%, respectively), thus supporting our findings. In addition, the frequency of the "protective" FINRISK haplotype CCCTAA was 23% in affected females of those families and 30% in unaffected females. Thus the obtained results of the "risk allele" of USF1 in these two studies are comparable, although we recognize that the ascertainment strategy for the FCHL families results in a biased selection of population alleles and complicates the estimation of any sex-specific effect in these rare families. Many previous studies have found the influence of USF1 to be more prominent among males [2,8], or have studied only males [9], whereas here we saw the most significant evidence of association among females. The lack of association among males at the population level in our cohorts could be explained by environmental covariates. CVD events are more common in males, most probably due to clustering of numerous lifestyle risk factors, including smoking, obesity, and high blood pressure, this increasing the environmental "noise" and complicating genetic analyses in males compared to females.
###end p 22
###begin p 23
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
The association of USF1 with CVD in females of two distinct population cohorts supports the real involvement of USF1 in CVD risk. Moreover, the trends of the hazard ratios for the risk-associated alleles of USF1 were the same in both FINRISK cohorts, and the same risk alleles of USF1 were associated both with CVD events and all-cause mortality among females, further supporting their significance. Finally, correcting for multiple testing with permutations providing a more stringent significance threshold for the original p-values still retained a significant association between USF1 variation and the risk of CVD and mortality among females.
###end p 23
###begin p 24
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b004">4</xref>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b007">7</xref>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b009">9</xref>
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
In the association analyses of SNPs with lipid parameters, we observed USF1 htSNPs to strongly associate with plasma cholesterol levels and non-HDL cholesterol especially among the male CVD cases. These findings confirm prior reports that USF1 variants contribute to differences in lipid profiles [2-4,7-9]. However, no associations with traditional risk factors were obtained that would explain the increased risk of CVD and mortality among female carriers of USF1 risk alleles. The question remains whether the impact of USF1 on lipid parameters among females is as powerful as among males, or if the gene variants have alternative ways of increasing the CVD risk-for example, through inflammation-related pathways.
###end p 24
###begin p 25
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1,</italic>
###xml 548 557 548 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b001">1</xref>
As noted previously, the strong LD of the USF1 locus extends the critical FCHL region to 46 kb in Finnish FCHL families [2]. This DNA region may harbor additional variants that represent true functional variants that affect CVD risk. Sequencing of the complete region in sufficiently large study samples would shed light on the risk-increasing variants of USF1, and would enable the detailed functional studies needed to establish their role. So far, functional data exist only for the most significantly associated SNP of the original FCHL study, rs2073658 [1].
###end p 25
###begin p 26
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
In conclusion, here we have shown that the risk effect of a gene identified in a rare set of FCHL families who are at exceptionally high risk for cardiovascular events can be confirmed in a population-based prospective follow-up study. We observed one "risk" and one "protective" allelic haplotype of USF1 that significantly contribute to the risk for CVD and all-cause mortality among females. To evaluate the significance of these results obtained in the Finnish cohorts for CVD risk more globally, other populations need to be analyzed. Still, this study demonstrates, to our knowledge for the first time, that USF1 gene variation may have a long-term predictive effect on CVD risk in females, and thus adds another piece of proof to the accumulating evidence that the gene plays an important role in the progression of CVD.
###end p 26
###begin title 27
Materials and Methods
###end title 27
###begin title 28
Study populations.
###end title 28
###begin p 29
###xml 55 56 55 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b005">5</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b010">10</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b010">10</xref>
###xml 263 270 <span type="species:ncbi:9606">persons</span>
###xml 608 615 <span type="species:ncbi:9606">persons</span>
Our population cohorts were collected via the FINRISK [5] studies. FINRISK surveys are carried out every 5 y and are designed to assess the prevalence and risk factors of cardiovascular diseases in Finland. The FINRISK-92 study contacted a random sample of 8,000 persons aged 25-64 y from four geographical areas of Finland (Helsinki region, southwestern Finland, North Karelia, and Kuopio region) as part of the WHO MONICA Project (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease, an international study conducted under the auspices of the World Health Organization) [10]. The persons were selected through random sampling of the population, stratified by sex, area, and 10-y age group (25-34, 35-44, 45-54, and 55-64 y). The protocol was as established by the WHO MONICA [10] Project.
###end p 29
###begin p 30
###xml 652 660 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g001">Figure 1</xref>
###xml 38 45 <span type="species:ncbi:9606">persons</span>
###xml 374 386 <span type="species:ncbi:9606">participants</span>
###xml 597 609 <span type="species:ncbi:9606">participants</span>
The FINRISK-97 study contacted 10,000 persons from the same regions, selected using the same sampling procedure and using the same protocols as the FINRISK-92 study, but including also the province of Oulu. In addition, 250 females and 500 males aged 65-74 y were included from two of the areas. At the beginning of the follow-up period, the overall response rates covering participants with all required information for the genetic study were 71% for males and 79% for females in the FINRISK-92 study, and 68% for males and 74% for females in the FINRISK-97 study, resulting in a total of 14,140 participants out of the 19,500 in the original sample (Figure 1). No overlap exists between the FINRISK-92 and the FINRISK-97 cohorts.
###end p 30
###begin p 31
###xml 122 134 <span type="species:ncbi:9606">participants</span>
The FINRISK-92 and FINRISK-97 studies were approved by the Ethical Committee of the National Public Health Institute, the participants gave an informed consent, and the principles of the Helsinki Declaration were followed.
###end p 31
###begin p 32
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b011">11</xref>
Both FINRISK-92 and -97 cohorts are participating in the ongoing MORGAM Project () [11], a multinational collaborative study.
###end p 32
###begin p 33
###xml 25 37 <span type="species:ncbi:9606">participants</span>
###xml 143 155 <span type="species:ncbi:9606">participants</span>
The follow-up period for participants of FINRISK-92 lasted from spring 1992 until the end of December 2001, a total of 10 y. In FINRISK-97 the participants were followed up for 7 y, from 1997 until the end of December 2003. More detailed information about the FINRISK cohorts and the follow-up procedures can be found in the cohort descriptions of the MORGAM Project ().
###end p 33
###begin title 34
Baseline examination and follow-up of FINRISK studies.
###end title 34
###begin p 35
###xml 21 33 <span type="species:ncbi:9606">participants</span>
###xml 540 552 <span type="species:ncbi:9606">participants</span>
At the baseline, all participants were asked to fill in a self-administered questionnaire and were physically examined. The physical examination included blood pressure, waist, hip, weight, and height measurements. The self-administered questionnaire asked respondents for information on the most established environmental cardiovascular risk factors, e.g., demographic variables, history of CVD, history of diabetes, medication, smoking, and additional lifestyle and dietary habits. Blood was collected in a "semifasting" state, i.e., the participants were instructed to fast for 4 h and to avoid fatty meals earlier during the day. Serum total cholesterol, HDL cholesterol, and triglyceride levels were measured. Whole blood was stored at -20 degreesC for DNA extraction.
###end p 35
###begin title 36
Case-cohort design.
###end title 36
###begin p 37
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b012">12</xref>
###xml 240 248 240 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g001">Figure 1</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b013">13</xref>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b014">14</xref>
###xml 2324 2326 2324 2326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b015">15</xref>
###xml 2327 2329 2327 2329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b017">17</xref>
###xml 151 163 <span type="species:ncbi:9606">participants</span>
###xml 271 283 <span type="species:ncbi:9606">participants</span>
###xml 510 522 <span type="species:ncbi:9606">participants</span>
We used a case-cohort design [12], in which DNA was genotyped only for stratified random samples-subcohorts-of the FINRISK-92 and -97 cohorts, and for participants experiencing death, coronary event, or stroke during the follow-up periods (Figure 1). In addition, DNA of participants experiencing venous thromboembolic event or reporting history of CVD at the baseline examination was genotyped (); however, venous thromboembolism and baseline CVD were not analyzed as endpoints in our genetic study. Further, participants with prevalent CVD were excluded from our genetic analyses, except when analyzing all-cause mortality, for which all subcohort members and all deaths were included regardless of their CVD history. Information about coronary and stroke events during the follow-up periods was obtained from several sources: specific myocardial infarction and stroke registers (FINAMI [13] and FINSTROKE [14]) complemented with record linkage of the study data with the National Causes of Death Register and the National Hospital Discharge Register. These country-wide, computerized registers cover every death of Finnish citizens and every hospitalization in Finland, and thus the coverage of follow-up for symptomatic CVD events was almost 100%. In the National Causes of Death Register International Classification of Diseases (ICD)-9 codes 410-414 and 798, and ICD-10 codes I21-I25, I46, R96, R98 and R99 were taken as coronary deaths. ICD-9 codes 433 (excluding 4330X, 4331X, 4339X of the Finnish modification of ICD-9; see ) and 434 (excluding 4349X), and ICD-10 code I63, were taken as ischemic stroke deaths. In the National Hospital Discharge Register ICD-9 codes 410-411, and ICD-10 codes I21-I22 and I20.0, were taken as nonfatal coronary events; and ICD-9 codes 433 (excluding 4330X, 4331X, 4339X) and 434 (excluding 4349X), and ICD-10 code I63, were taken as nonfatal ischemic stroke events. ICD-9 was used in Finland until 31 December 1995, and ICD-10 after that. The combination of FINAMI register and the National Hospital Discharge Register was also used to identify revascularization procedures (CABG and PTCA) during the follow-up period. The validity of cardiovascular diagnoses in the Finnish Causes of Death Register and the Hospital Discharge Register has been documented in several publications [15-17].
###end p 37
###begin p 38
###xml 46 58 <span type="species:ncbi:9606">participants</span>
###xml 102 114 <span type="species:ncbi:9606">participants</span>
Unique Finnish social security numbers of the participants were compared between the two cohorts, and participants already enrolled in the FINRISK-92 cohort were excluded from the FINRISK-97 cohort.
###end p 38
###begin p 39
###xml 282 290 282 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g001">Figure 1</xref>
###xml 295 302 295 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t001">Table 1</xref>
###xml 513 521 513 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g001">Figure 1</xref>
###xml 797 804 797 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t002">Table 2</xref>
###xml 119 126 <span type="species:ncbi:9606">persons</span>
###xml 714 721 <span type="species:ncbi:9606">persons</span>
In the present study, incident CVD and all-cause mortality were analyzed as endpoints. Incident CVD cases included the persons without prevalent CVD at baseline who suffered a fatal or nonfatal ischemic stroke event, or fatal or nonfatal coronary event during the follow-up period (Figure 1 and Table 1). The number of main study endpoints was used as reference to determine the size of the random subcohorts to be selected from the original population cohorts and age was controlled through sampling weights () (Figure 1). The selection of the subcohort members was independent of the selection of cases, thus of the 374 male and 154 female incident CVD cases, 72 were also part of the subcohorts. Altogether 610 persons (180 females and 430 males) died during the follow-ups of the two cohorts. Table 2 shows the baseline characteristics of the incident CVD cases and subcohort members free of CVD.
###end p 39
###begin title 40
DNA extraction.
###end title 40
###begin p 41
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b018">18</xref>
DNA was extracted from EDTA-treated whole-blood samples using a standard phenol-chloroform method modified from Vandenplas et al. [18]. DNA of 23 FINRISK-92 samples was extracted by a salt-precipitation method.
###end p 41
###begin title 42
Markers.
###end title 42
###begin p 43
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 118 126 118 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020069-g002">Figure 2</xref>
###xml 129 138 129 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rs2073658</italic>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b006">6</xref>
To capture the allelic diversity of the 5.69 kb USF1 gene in the FINRISK-92 and -97 cohorts, we genotyped six htSNPs (Figure 2). Rs2073658 in intron 7 of the USF1 gene was the most significantly associated SNP in our previous FCHL study [2]. Additional htSNPs were selected using the SeattleSNPs Variation Discovery Resource [6]. All common (average minor allele frequency > 4%) LD select bins for European descent were covered with our SNP selection.
###end p 43
###begin p 44
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rs2516839</italic>
###xml 14 23 14 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1556259</italic>
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b002">2</xref>
###xml 106 116 106 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rs10908821</italic>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F11R),</italic>
###xml 198 207 198 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 209 218 209 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rs2774276</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1,</italic>
###xml 268 277 268 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658</italic>
###xml 283 292 283 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 430 439 430 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1556259</italic>
Rs2516839 and rs1556259 were included in our family-based study [2], but showed no association with FCHL. Rs10908821 is located in an intron of the F11 receptor gene (F11R), 2.23 kb downstream from rs2073658. Rs2774276 resides in intron 5 of USF1, 0.95 kb upstream of rs2073658. SNP rs2774279 results in a synonymous amino acid substitution (874 R/R) in an exon of a predicted gene LOC257106, and is located 2.90 kb upstream from rs1556259.
###end p 44
###begin title 45
Genotyping.
###end title 45
###begin p 46
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b019">19</xref>
###xml 161 182 161 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2073658, rs2516839,</italic>
###xml 187 196 187 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774279</italic>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b019">19</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b020">20</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b019">19</xref>
Most of the genotyping was performed using the MassARRAY System (Sequenom, San Diego, California, United States), with a protocol described elsewhere [19]. SNPs rs2073658, rs2516839, and rs2774279 were genotyped in the FINRISK-92 study sample using allele-specific primer extension on microarrays with a protocol described elsewhere [19,20]. For MassARRAY System genotyping, 81 low-yield DNA samples of the FINRISK-92 study sample and 19 low-yield DNA samples of the FINRISK-97 study sample were first amplified in replicates using GenomePhi DNA amplification kit (GE Healthcare UK, Buckinghamshire, England) as specified in the manufacturer's instructions and genotyped as described [19].
###end p 46
###begin p 47
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 563 572 563 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2774276</italic>
###xml 81 93 <span type="species:ncbi:9606">participants</span>
###xml 203 215 <span type="species:ncbi:9606">participants</span>
The staff in the genotyping laboratory were blinded to sex and disease status of participants. To control for sample mix-ups, all samples were genotyped for sex, and the data were compared to the sex of participants as recorded in the database. Plate-specific duplicates and water samples were used to control for plate-handling errors. Of the samples genotyped, 5% were blinded duplicates. The USF1 marker genotypes of the blinded duplicate pairs were compared after genotyping and were all found to be consistent. The success rate of genotyping was 98% for SNP rs2774276 and 97% for all other SNPs.
###end p 47
###begin title 48
Haplotype estimations.
###end title 48
###begin p 49
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b021">21</xref>
LD and haplotype block analysis and haplotype population frequency estimations were performed with Haploview version 3.2 [21] using the two FINRISK subcohorts combined. Subcohort members with over 50% missing genotypes were excluded from the analysis, thus 782 individuals were used in the haplotype estimations.
###end p 49
###begin title 50
Data analyses.
###end title 50
###begin p 51
Allele and genotype frequencies were determined from the data, and deviation from the Hardy-Weinberg equilibrium was tested using Pearson's chi-square. Pearson's chi-square statistic was used to compare allele frequencies between incident CVD cases and subcohorts free of CVD.
###end p 51
###begin p 52
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b012">12</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b022">22</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020069-b023">23</xref>
###xml 787 798 787 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(rs10908821</italic>
###xml 803 814 803 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1556259),</italic>
A weighted Cox proportional hazards model, modified to account for the case-cohort sampling design, was used for risk analyses with the variance correction based on the published literature using SAS PHREG procedure [12,22,23]. Age represented the time measure in the models. Covariates known to associate with CVD (age, sex, hypertension, smoking, diabetes, total cholesterol to HDL ratio, and BMI) were included in multivariate models as potential confounders. When analyzing CVD, individuals with prevalent CVD at the baseline were excluded from analyses. Analyses were stratified for eastern and western Finland, and the cohort was used as a covariate. Carriership of the minor and major allele was analyzed for each SNP, except for the two SNPs with lowest minor allele frequencies (rs10908821 and rs1556259), for which only the carriership of the minor allele was used in the analysis due to the low number of individuals homozygous for the minor allele.
###end p 52
###begin p 53
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 456 464 456 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t005">Tables 5</xref>
To determine the relation between the USF1 htSNPs and several baseline variables, we computed age-, sex-, geographical area-, and cohort-adjusted mean values for SNP allele groups and tested the difference with analyses of covariance implemented in the SAS "PROC GLM" procedure. Before analyses, the variables HDL and triglyceride were log-transformed to correct them to be normally distributed. Mean values of the variables are displayed as crude data on Tables 5 and S1. Individuals deviating +/- 4 standard deviations (SD) from the mean were excluded as outliers from the analyses. Further, the analyses were conducted using subcohort members free of CVD at baseline and incident CVD cases.
###end p 53
###begin p 54
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 399 400 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To evaluate the significance of our findings, we permuted the genotype while retaining the phenotype data within sex/cohort groups, and repeated the same analyses that were performed with the actual dataset, recording the minimum p-value observed. We repeated this procedure 1,000 times and took the fifth percentile of these minimum p-values as the new multiple-testing corrected threshold for the p-values obtained with the original data.
###end p 54
###begin p 55
Statistical analyses were carried out using the SAS statistical software (versions 8.2. and 9.1 for Windows) (SAS OnlineDoc, Version 8, 1999; SAS Institute, Cary, North Carolina, United States).
###end p 55
###begin title 56
Supporting Information
###end title 56
###begin title 57
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
Association between USF1 SNP Alleles and Lipids, BMI, and Waist-To-Hip Ratio in FINRISK Subcohort Males and Females
###end title 57
###begin p 58
(27 KB XLS)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin title 60
Accession Numbers
###end title 60
###begin p 61
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F11R</italic>
###xml 125 128 <span type="species:ncbi:9606">Man</span>
The Entrez Gene () accession numbers for USF1 and F11R are 7391 and 50848, respectively. The online Mendelian Inheritance in Man (OMIM) ) accession numbers for FCHL, metabolic syndrome, and type II diabetes are 144250, 605552, and 125853, respectively.
###end p 61
###begin p 62
We gratefully acknowledge the Finnish individuals who volunteered to participate in this study. We thank MSc. Minttu Jussila, Mrs. Siv Knaappila, Ms. Minna Levander, Mrs. Anne Nyberg, and Ms. Arja Tapio for their excellent technical assistance. Mr. Juri Ahokas, Mr. Zygimantas Cepaitis, and Mr. Tero Hiekkalinna are thanked for their assistance in the data management. Dr. Juha Karvanen and Mr. Olli Saarela are thanked for their assistance in the data analysis.
###end p 62
###begin p 63
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 1090 1098 <span type="species:ncbi:9606">patients</span>
Author contributions. K. Komulainen participated in the genotyping of the samples and data analyses. M. Alanne was in charge of the sample management for the study and participated in the data analyses. K. Auro participated in the genotyping of the samples and data analyses. R. Kilpikari and K. Salminen participated in the data analyses. P. Pajukanta provided SNP information and participated in the SNP selection for the study. J. Saarela participated in the optimization of the microarray genotyping and analyzing the results of the genotyping. P. Ellonen participated in the optimization of the microarray genotyping and analyzing the results of the genotyping. S. Kulathinal participated in the study design, the assessment of the quality of the phenotypic data, and data analyses. K. Kuulasmaa participated in the study design and the assessment of the quality of the phenotypic data and data analyses. K. Silander participated in the genotyping of the samples and the whole genome amplification of DNA. V. Salomaa participated in the design of the study, recruitment of the FINRISK patients, assignment of clinical diagnoses, and data analyses. M. Perola participated in the DNA extraction, study design, and data analyses. L. Peltonen is the principal investigator, with the responsibility of overall study design and data analyses. All authors participated in writing the paper.
###end p 63
###begin title 64
Abbreviations
###end title 64
###begin p 65
body mass index
###end p 65
###begin p 66
coronary heart disease
###end p 66
###begin p 67
confidence interval
###end p 67
###begin p 68
cardiovascular disease
###end p 68
###begin p 69
familial combined hyperlipidemia
###end p 69
###begin p 70
high-density lipoprotein
###end p 70
###begin p 71
hazard ratio
###end p 71
###begin p 72
haplotype-tagging single nucleotide polymorphism
###end p 72
###begin p 73
International Classification of Diseases
###end p 73
###begin p 74
linkage disequilibrium
###end p 74
###begin p 75
standard deviation
###end p 75
###begin p 76
single nucleotide polymorphism
###end p 76
###begin p 77
upstream transcription factor 1
###end p 77
###begin title 78
References
###end title 78
###begin article-title 79
USF1 and dyslipidemias: Converging evidence for a functional intronic variant
###end article-title 79
###begin article-title 80
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)
###end article-title 80
###begin article-title 81
Familial combined hyperlipidemia in Mexicans: Association with upstream transcription factor 1 and linkage on chromosome 16q24.1
###end article-title 81
###begin article-title 82
The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population
###end article-title 82
###begin article-title 83
Cardiovascular risk factor changes in Finland, 1972-1997
###end article-title 83
###begin article-title 84
Upstream transcription factor-1 gene polymorphism is associated with increased adipocyte lipolysis
###end article-title 84
###begin article-title 85
Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides
###end article-title 85
###begin article-title 86
Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II
###end article-title 86
###begin article-title 87
MORGAM (an international pooling of cardiovascular cohorts)
###end article-title 87
###begin article-title 88
A case-cohort design for epidemiologic cohort studies and disease prevention trials
###end article-title 88
###begin article-title 89
Trends in coronary events in Finland during 1983-1997. The FINAMI study
###end article-title 89
###begin article-title 90
Continuous 15-year decrease in incidence and mortality of stroke in Finland: The FINSTROKE study
###end article-title 90
###begin article-title 91
Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland
###end article-title 91
###begin article-title 92
Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland
###end article-title 92
###begin article-title 93
The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease
###end article-title 93
###begin article-title 94
Blot hybridisation analysis of genomic DNA
###end article-title 94
###begin article-title 95
Evaluating whole genome amplification via multiply-primed rolling circle amplification for SNP genotyping of samples with low DNA yield
###end article-title 95
###begin article-title 96
A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays
###end article-title 96
###begin article-title 97
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 97
###begin article-title 98
The robust inference for the Cox Proportional Hazards Model
###end article-title 98
###begin article-title 99
Robust variance estimation for the case-cohort design
###end article-title 99
###begin title 100
Figures and Tables
###end title 100
###begin title 101
A Description of the FINRISK 1992 and 1997 Cohorts
###end title 101
###begin p 102
###xml 659 666 659 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020069-t001">Table 1</xref>
###xml 196 203 <span type="species:ncbi:9606">Persons</span>
Compared to FINRISK-92, the FINRISK-97 cohort includes an additional sample of individuals aged 65-74 y. Numbers for this additional sample are described at the right-hand side for each endpoint. Persons examined refers to cohort individuals for whom information on smoking, blood pressure, cholesterol, and DNA, as well as consent for the use of DNA to study CHD and stroke, were available. Subcohorts are stratified random samples of the original cohorts including also cases. Mortality cases show total mortality, including also those who died from CHD or stroke. Thus, numbers in the boxes of subcohorts and outcome events are not mutually exclusive (see Table 1). F, females; M, males.
###end p 102
###begin title 103
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
The Haplotype Structure in the USF1 Gene Locus
###end title 103
###begin p 104
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
The six genotyped SNPs from the USF1 gene locus resulted in five common haplotypes. The haplotype frequencies were calculated for the two FINRISK subcohorts combined.
###end p 104
###begin p 105
Numbers of Study Subjects in the Random Subcohort and with Different Endpoint Events in FINRISK-92 and FINRISK-97 Cohorts
###end p 105
###begin p 106
Baseline Characteristics of Cardiovascular Cases and Subcohort
###end p 106
###begin p 107
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
Minor Allele Frequencies of USF1 htSNPs for CVD Cases and the Subcohort
###end p 107
###begin p 108
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
Risk of a Cardiovascular Event and All-Cause Mortality for the USF1 SNPsa
###end p 108
###begin p 109
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
Association between USF1 SNP Alleles and Lipids, BMI, and Waist-To-Hip Ratio in FINRISK CVD Case Males and Females
###end p 109
###begin p 110
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 110
###begin p 111
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This study has been supported by the Center of Excellence in Disease Genetics of the Finnish Academy, Biocentrum Helsinki; awards from the Finnish Academy (grant 53646), Sigrid Juselius Foundation, Finnish Heart Foundation, and Jenny and Antti Wihuri Foundation; NIH grants HL-28481 and HL-70150; and the American Heart Association grant 0430180N. GenomEUtwin-project is supported by the European Commission under the program "Quality of Life and Management of the Living Resources" of 5th Framework Programme (QLG2-CT-2002-01254).
###end p 111
###begin p 112
A previous version of this article appeared as an Early Online Release on March 23, 2006 (DOI: ).
###end p 112
###begin p 113
###xml 142 147 <span type="species:ncbi:9606">women</span>
Citation: Komulainen K, Alanne M, Auro K, Kilpikari R, Pajukanta P, et al. (2006) Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genet 2(5): e69. DOI: 10.1371/journal.pgen.0020069
###end p 113

